BIOBOTS - THE FUTURE OF BIOMEDICAL ENGINEERING: A MINI REVIEW
Universal Journal of Pharmaceutical Research · 2025
DOI: 10.22270/ujpr.v10i2.1319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Universal Journal of Pharmaceutical Research, 2025. Verfasst von Mostafa Essam Eissa. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Biobots (Biorobots), engineered living systems, are poised to revolutionize the fields of medicine, biotechnology and environmental science. They can be created from either normal living cells and/or post-mortem cells. This short papershades light into the fundamental concepts, design principles and diverse applications of biobots. The state-of-the-art advancements in biomaterials, cell engineering and control systems that underpin the development of these intricate machines will be explored. Furthermore, the ethical implications and regulatory considerations associated with their deployment are discussed. By highlighting current research and future perspectives in this emerging technology, this article aims to explore the potential of biobots to revolutionize healthcare, particularly in the areas of drug delivery, tissue engineering and regenerative medicine. Peer Review History: Received 6 February 2025; Reviewed 10 March 2025; Accepted 13 April; Available online 15 May 2025
Zitieren
APA
Eissa, M. E. (2025). BIOBOTS - THE FUTURE OF BIOMEDICAL ENGINEERING: A MINI REVIEW. Universal Journal of Pharmaceutical Research. https://doi.org/10.22270/ujpr.v10i2.1319
Vancouver
Eissa ME. BIOBOTS - THE FUTURE OF BIOMEDICAL ENGINEERING: A MINI REVIEW. Universal Journal of Pharmaceutical Research. 2025. doi:10.22270/ujpr.v10i2.1319
BibTeX
@article{Eissa2025,
author = {Eissa, Mostafa Essam},
title = {BIOBOTS - THE FUTURE OF BIOMEDICAL ENGINEERING: A MINI REVIEW},
journal = {Universal Journal of Pharmaceutical Research},
year = {2025},
doi = {10.22270/ujpr.v10i2.1319}
}
EUVIMED